EVERTOR 5MG TABLETS | EVEROLIMUS | MHP - PowerPoint PPT Presentation

About This Presentation
Title:

EVERTOR 5MG TABLETS | EVEROLIMUS | MHP

Description:

Evertor 5mg is a derivative of Rapamycin (sirolimus) and works similarly to Rapamycin as an mTOR (mammalian target of rapamycin) inhibitor. – PowerPoint PPT presentation

Number of Views:18

less

Transcript and Presenter's Notes

Title: EVERTOR 5MG TABLETS | EVEROLIMUS | MHP


1
EVERTOR 5MG TABLETS EVEROLIMUS MHP
  • Million Health Pharmaceuticals

2
DESCRIPITION
  • Evertor 5mg is a derivative of Rapamycin
    (sirolimus) and works similarly to Rapamycin as
    an mTOR (mammalian target of rapamycin)
    inhibitor.It is normally used as an
    immunosuppressant to prevent rejection of organ
    transplants.In a similar fashion to other mTOR
    inhibitors Everolimus' effect is solely on the
    mTORC1 protein and not on the mTORC2 protein.

3
Brain carcinoma
4
PRESCRIBING INFORMATION
  • Evertor 5mg tablets are mainly indicated for the
    treatment of Renal carcinoma.
  • Evertor 5mg tablets are mainly indicated for the
    treatment of Breast carcinoma.
  • Evertor 5mg tablets are mainly indicated for the
    treatment of Brain carcinoma.
  • Evertor 5mg is also used in various advanced
    stage cancer in stomach, intestines or pancreas 

5
MECHANISM OF ACTION
  • Everolimus is an mTOR prohibitor, joints at high
    compatibility to FK506 binding protein 12, via
    producing drug complex whichinhibits the specific
    of mTOR.
  • This inhibition decreases the activity of
    effectors downstream, that may cause blockage of
    cell progression from G1 into S phase,
    subsequently causes cell growth arrest and
    apoptosis

6
PRODUCT DETAILS
  • Brand EvertorIngredients Everolimus Strength
    5MGManufactured Biocon Pharma Package 10
    tablets 

7
PHARMACOKINETICS
  • ABSORPTION
  • The high plasma concentration time of Everolimus
    is 1 to 2 hours.
  • The effect of food with Evertor 5mg that with
    heavy meal Reduction of systemic exposure
    to Evertor 5mg10mg, and the high blood plasma
    concentration by 54.
  • DISTRIBUTION
  • Evertor 5mg human plasma protein bound with the
    range of 74.80 ml/kg
  • METABOLISM
  • The metabolism of Everolimus is occurred in
    liver, which is a substrate of CYP3A4.

8
DOSAGE MANAGEMENT
  • In breast cancer, renal cell cancer, pancreatic
    cancer, Neuro endocrine cancerThe prescribed
    dosage is 10mg should be taken as a single
    dose.In Brain or intracranial cancerThe
    prescribed dosage of Evertor is 4.5mg/m2 orally
    as a single dose.In pediatricThe usual
    pediatric dosage of Evertor in brain or
    intracranial tumor is 4.5mg/m2 should be taken
    orally as a single dose.

9
PRECAUTIONS
  • Lymphomas Increased exposure of skin cancers,
    patient may protect from UV lightSerious
    infections Patients receiving Evertor 5mg have
    high risk of acquiring various infections related
    to bacteria, virus, and fungi.Anti-microbial
    agents are preferred for the suspected
    patients.Hepatic artery thrombosis In liver
    transplant patients, Evertor 5mg therapy should
    not be recommended.

10
SIDE EFFECTS
  • Hypersensitivity reactions Lymphomas other
    malignancy Serious infections Kidney graft
    thrombosis Hepatic artery thrombosis
    Nephrotoxicity Hyperlipemia Angioedema
    Interstitial lung disease Thrombocytopenia
    Male infertility Proteinuria New commencement
    of diabetes.

11
DRUG INTERACTION
  •  Evertor 5mg interaction with strong inhibitor
    of CYP3A4, or P-gp, leads to cause decreasing the
    efflux of Everolimus and increase the plasma
    concentration of Everolimus Combination
    of Evertor 5mg with verapamil leads to increasing
    the plasma concentration of Everolimus.
    Combination of Evertor 5mg with Atorvastatin or
    pravastatin causes rhabdomyolysis, due to
    increasing concentration of lipid lowering
    agents. Evertor 5mg combination with strong
    CYP3A4 inducers, causes increasing the exposure
    of Everolimus. Concomitant use of Evertor
    5mg with cyclosporine causes increasing the AUC
    level of Everolimus frequently. Evertor
    5mg tablet is interaction with ketoconazole or
    other CYP3A4 inhibitors causes increasing the
    plasma concentration and AUC of Everolimus.

12
CONTRAINDICATIONS
  • Some anaphylactic reaction occurs, if patients
    are contraindicated to the components present in
    the Evertor 5mg tablets.

13
PREGNANCY
  • Pregnancy category C Evertor 5mg is needed only
    by the patients after knowing the benefits to the
    mother outweighs the risk to fetus.

14
STORAGE
  • Evertor 5mg tablet should be kept at 25C
  • Keep the tablet away from moisture, heat and
    lightDispense only in original container

15
MISSED DOSE
  • If patient failed to take a single dose, patients
    must consult with medical practitioner and follow
    the instructions given by them.
  • Or the missed dose should be avoiding and follow
    the regular dosing schedule.

16
OVERDOSAGE
  • The over dosage of Everolimus is rarely occur, in
    case of over dosage patient must be provide with
    supportive measures. The acute toxicity of
    Everolimus over dosage should be monitored.

17
CONTACT US
  • MOBILE NO 91-9940472902
  • EMAIL   millionhealthpharmaceuticals_at_gmail.com
  • WEBSITEURL https//millionpharma.com/evertor-5-mg
    .php
Write a Comment
User Comments (0)
About PowerShow.com